DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Alosetron

Alosetron

  • FDA Warns About an Increased Risk of Serious Pancreatitis with Irritable Bowel Drug Viberzi (Eluxadoline) in Patients Without a Gallbladder

    FDA Warns About an Increased Risk of Serious Pancreatitis with Irritable Bowel Drug Viberzi (Eluxadoline) in Patients Without a Gallbladder

  • Therapeutic Class Overview Irritable Bowel Syndrome Agents

    Therapeutic Class Overview Irritable Bowel Syndrome Agents

  • Prophylactic Antiemetic Therapy with Ondansetron, Granisetron and Metoclopramide in Patients Undergoing Laparoscopic Cholecystectomy Under GA

    Prophylactic Antiemetic Therapy with Ondansetron, Granisetron and Metoclopramide in Patients Undergoing Laparoscopic Cholecystectomy Under GA

  • Antidepressants for Functional Gastrointestinal Disorders

    Antidepressants for Functional Gastrointestinal Disorders

  • Irritable Bowel Syndrome-Diarrhea

    Irritable Bowel Syndrome-Diarrhea

  • Efficacy of Eluxadoline in Irritable Bowel Syndrome with Diarrhea

    Efficacy of Eluxadoline in Irritable Bowel Syndrome with Diarrhea

  • Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gutlbrain Interaction): a Rome Foundation Working Team Report Douglas A

    Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gutlbrain Interaction): a Rome Foundation Working Team Report Douglas A

  • 2015.09 IBS Drug Class Review.Pdf

    2015.09 IBS Drug Class Review.Pdf

  • Viberzi™ (Eluxadoline) – Safety Update

    Viberzi™ (Eluxadoline) – Safety Update

  • Drug Interactions with Tobacco Smoke: Implications for Patient Care

    Drug Interactions with Tobacco Smoke: Implications for Patient Care

  • Hepatic Encephalopathy

    Hepatic Encephalopathy

  • Soma® ) to Alosetron (Lotronex® ): a New Treatment Be Restricted for Irritable Bowel Syndrome

    Soma® ) to Alosetron (Lotronex® ): a New Treatment Be Restricted for Irritable Bowel Syndrome

  • Irritable Bowel Syndrome — Clinical Evaluation of Drugs for Treatment

    Irritable Bowel Syndrome — Clinical Evaluation of Drugs for Treatment

  • Efficacy and Tolerability of Renzapride in Irritable Bowel Syndrome: a Meta-Analysis of Randomized, Controlled Clinical Trials Including 2528 Patients

    Efficacy and Tolerability of Renzapride in Irritable Bowel Syndrome: a Meta-Analysis of Randomized, Controlled Clinical Trials Including 2528 Patients

  • LOTRONEX (Alosetron Hydrochloride) Tablets • Initial U.S

    LOTRONEX (Alosetron Hydrochloride) Tablets • Initial U.S

  • Viberzi® Common Name: Eluxadoline PDL Category: GI, Constipation-IBS-OIC

    Viberzi® Common Name: Eluxadoline PDL Category: GI, Constipation-IBS-OIC

  • Alosetron Hydrochloride Tablets Or Placebo

    Alosetron Hydrochloride Tablets Or Placebo

  • How the FDA Manages Drug Safety with Black Box Warnings, Use Restrictions, and Drug Removal, with Attention to Gastrointestinal Medications

    How the FDA Manages Drug Safety with Black Box Warnings, Use Restrictions, and Drug Removal, with Attention to Gastrointestinal Medications

Top View
  • Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
  • CCHCS Care Guide: Intoxication and Withdrawal SUMMARY DECISION SUPPORT PATIENT EDUCATION/SELF-MANAGEMENT GOALS ALERTS
  • Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission R ICHARD A
  • Long-Term Efficacy and Safety of Ramosetron in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
  • Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission
  • Neuronal 5-HT Receptors and SERT
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Lotronex (Alosetron Hydrochloride)
  • Irritable Bowel Syndrome (IBS): Introduction
  • Drug Class Review Selective Serotonin Reuptake Inhibitors
  • Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
  • Brain-Gut Interactions in IBS
  • Alosetron (Lotronex) Reference Number: CP.CPA.65 Effective Date: 11.16.16 Last Review Date: 11.17 Revision Log Line of Business: Medicaid – Medi-Cal
  • Interactions with Entry & Integrase Inhibitors
  • Lotronex) Reference Number: CP.PMN.153 Effective Date: 11.16.16 Last Review Date: 11.20 Line of Business: Commercial, Medicaid Revision Log
  • 5-HT Receptors and Their Ligands, Tocris Reviews No
  • Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders Meagan M
  • Efficacy of Combination Therapy with Probiotics and Mosapride In


© 2024 Docslib.org    Feedback